Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT00193869
Registration number
NCT00193869
Ethics application status
Date submitted
11/09/2005
Date registered
19/09/2005
Date last updated
10/05/2007
Titles & IDs
Public title
SuperDEX Trial (Comparison of Two Doses of Dexamethasone for Malignant Spinal Cord Compression Treated by Radiotherapy).
Query!
Scientific title
A Pilot Randomised Comparison of Dexamethasone 96 mg Versus 16 mg Per Day for Malignant Spinal Cord Compression Treated by Radiotherapy
Query!
Secondary ID [1]
0
0
TROG 01.05
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Spinal Cord Compression From Neoplasm Metastasis
0
0
Query!
Condition category
Condition code
Injuries and Accidents
0
0
0
0
Query!
Other injuries and accidents
Query!
Neurological
0
0
0
0
Query!
Other neurological disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Drugs - Dexamethasone
Treatment: Drugs: Dexamethasone
Query!
Intervention code [1]
0
0
Treatment: Drugs
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Satisfactory recruitment
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
Failure to accrue 30 patients in 15 months will initiate early closure of this study.
Query!
Primary outcome [2]
0
0
Acceptable steroid toxicity rate at 28 days with reference to baseline.
Query!
Assessment method [2]
0
0
Query!
Timepoint [2]
0
0
28 days
Query!
Secondary outcome [1]
0
0
Ambulation rates at 1 month
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
1 month
Query!
Secondary outcome [2]
0
0
Barthel Index
Query!
Assessment method [2]
0
0
Query!
Timepoint [2]
0
0
Final analysis when all patients have been followed for 1 month
Query!
Secondary outcome [3]
0
0
Functional Independence (FIM)
Query!
Assessment method [3]
0
0
Query!
Timepoint [3]
0
0
Final analysis when all patients have been followed for 1 month
Query!
Secondary outcome [4]
0
0
Functional Improvement Score (FIS)within 2 weeks with reference to baseline
Query!
Assessment method [4]
0
0
Query!
Timepoint [4]
0
0
2 weeks
Query!
Secondary outcome [5]
0
0
Pain
Query!
Assessment method [5]
0
0
Query!
Timepoint [5]
0
0
Final analysis when all patients have been followed for 1 month
Query!
Eligibility
Key inclusion criteria
- Malignant spinal cord compression with at least one of pain, weakness, sensory
disturbance or sphincter disturbance
- Histology not required if prior biopsy proven malignancy
- Any stage
- Age >16 years
- ECOG 1-3 prior to cord compression event
- Minimum power 1 of 5 point scale Must not be paraplegic
- Minimum expected survival 2 months
- Relevant minimum lab values
- Patients capable of childbearing using adequate contraception
- Written informed consent
Query!
Minimum age
17
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
- Prior radiotherapy to within vertebral±one level affected by cord compression
- Prior treatment for spinal cord compression at the current level
- Histology is lymphoma or myeloma
- Power less than 1 of 5
- More than 12 hours after initiation of dexamethasone>4mg/24hr
- Pre-existing co-morbid conditions - peptic ulceration or cardiac failure
- Allergy to study medications
- Multilevel cord compression or meningeal carcinomatosis
- Pregnant or lactating
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 2
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/09/2001
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
1/12/2003
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
20
Query!
Recruitment in Australia
Recruitment state(s)
NSW
Query!
Recruitment hospital [1]
0
0
St George Hospital - Kogarah
Query!
Recruitment postcode(s) [1]
0
0
2217 - Kogarah
Query!
Funding & Sponsors
Primary sponsor type
Other
Query!
Name
Trans Tasman Radiation Oncology Group
Query!
Address
Query!
Country
Query!
Other collaborator category [1]
0
0
Other
Query!
Name [1]
0
0
Cancer Council New South Wales
Query!
Address [1]
0
0
Query!
Country [1]
0
0
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The study aimed to pilot the viability of a full scale randomised comparison of 2 steroid
doses in malignant spinal cord compression, to establish safety of high dose dexamethasone in
this setting in Australia, to test web registration and randomisation and to compare
different functional outcome measures.
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT00193869
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Peter Graham, FRANZCR
Query!
Address
0
0
St George Hospital
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT00193869
Download to PDF